BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 13, 2014
View Archived Issues
Research sheds light on HMG-1 expression in MS brain tissue
Read More
Oxford BioMedica and Novartis expand LentiVector collaboration
Read More
Researchers at Edison Pharmaceuticals disclose new agents for Friedreich's ataxia
Read More
New aldehyde compounds disclosed for sickle cell disease and other disorders
Read More
Chinese group patents new ALK inhibitors for cancer
Read More
Novel viral entry inhibitors synthesized for DENV infection
Read More
Merck & Co. divulges new JAK inhibitors
Read More
First-in-human results for BI-655066 in psoriasis
Read More
Omniox receives Wellcome Trust grant to develop oxygen carrier OMX-4.80 for cancer
Read More
Ebola vaccine studied in healthcare workers in Mali
Read More
BCX-4161 shows efficacy and safety in OPuS-1 trial
Read More
Deciphera receives orphan drug designation for gastrointestinal stromal tumor agent
Read More
Novel platelet protein biochip used to identify AD biomarkers
Read More
FDA approves Harvoni for hepatitis C
Read More
FDA approves netupitant/palonosetron combination for CINV
Read More
World Thrombosis Day: Advocating for more effective prevention, diagnosis and treatment options
Read More
Prosensa starts rolling NDA submission for drisapersen
Read More
Endo to acquire Auxilium Pharmaceuticals
Read More
Biotron reports promising data from phase II trial of BIT-225 in HCV
Read More
FDA approves Bard's paclitaxel-coated angioplasty balloon
Read More
Galecto Biotech initiates phase I/II trial of galectin-3 inhibitor for IPF
Read More
Biogen Idec files MAA for Elocta in Europe
Read More
Impax signs definitive agreement to acquire Tower Holdings and Lineage Therapeutics
Read More
Reata starts trial of RTA-408 and ipilimumab in melanoma
Read More
Orexo applies to FDA to expand Zubsolv label to include initiation of opioid dependence therapy
Read More